Velneperit (S-2367)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Velneperit (S-2367), covering 2018-05-01 to 2018-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects [Phase 2]